| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/bmcsb/AlaimoBCFGP15 |
| P6179 | Dimensions Publication ID | 1026982827 |
| P356 | DOI | 10.1186/1752-0509-9-S3-S4 |
| P932 | PMC publication ID | 4464606 |
| P698 | PubMed publication ID | 26050742 |
| P50 | author | Alfredo Pulvirenti | Q51703731 |
| Vincenzo Bonnici | Q58145198 | ||
| Salvatore Alaimo | Q85325873 | ||
| Rosalba Giugno | Q51703723 | ||
| P2093 | author name string | Alfredo Ferro | |
| Damiano Cancemi | |||
| P2860 | cites work | DrugBank: a comprehensive resource for in silico drug discovery and exploration | Q24188653 |
| Emergent behavior of growing knowledge about molecular interactions. | Q51962700 | ||
| Metabolic network analysis revealed distinct routes of deletion effects between essential and non-essential genes. | Q54343586 | ||
| Survivin, cancer networks and pathway-directed drug discovery. | Q55046676 | ||
| Drug discovery. Repurposing with a difference. | Q55051971 | ||
| Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE | Q61447401 | ||
| Bipartite network projection and personal recommendation | Q81581104 | ||
| DCDB: drug combination database | Q82329206 | ||
| Mechanisms of drug combinations: interaction and network perspectives | Q83265745 | ||
| The Reactome pathway knowledgebase | Q24567743 | ||
| DrugBank 3.0: a comprehensive resource for 'omics' research on drugs | Q24612505 | ||
| Pathway Commons, a web resource for biological pathway data | Q24615770 | ||
| Stable isotope-resolved metabolomics and applications for drug development | Q24629149 | ||
| DrugBank: a knowledgebase for drugs, drug actions and drug targets | Q24650300 | ||
| PID: the Pathway Interaction Database | Q24656193 | ||
| Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review | Q27008867 | ||
| STITCH 4: integration of protein-chemical interactions with user data | Q27136674 | ||
| STITCH 2: an interaction network database for small molecules and proteins | Q27137016 | ||
| Shift in the equilibrium between on and off states of the allosteric switch in Ras-GppNHp affected by small molecules and bulk solvent composition | Q27681880 | ||
| The BioPAX community standard for pathway data sharing | Q27987775 | ||
| Network pharmacology: the next paradigm in drug discovery | Q28297997 | ||
| STITCH: interaction networks of chemicals and proteins | Q28465606 | ||
| Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis | Q28481496 | ||
| Prediction of drug-target interactions and drug repositioning via network-based inference | Q28483634 | ||
| The Connectivity Map: a new tool for biomedical research | Q28530408 | ||
| GRAPES: a software for parallel searching on biological graphs targeting multi-core architectures | Q28534581 | ||
| Pathway analysis for drug repositioning based on public database mining | Q28657698 | ||
| The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease | Q29547614 | ||
| Drug-target network | Q29614447 | ||
| Drug repositioning: identifying and developing new uses for existing drugs | Q29614779 | ||
| Biological robustness | Q29617468 | ||
| STITCH 3: zooming in on protein-chemical interactions | Q30002340 | ||
| Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease | Q30526431 | ||
| A subgraph isomorphism algorithm and its application to biochemical data. | Q30652514 | ||
| GraphFind: enhancing graph searching by low support data mining techniques | Q31154578 | ||
| SING: subgraph search in non-homogeneous graphs | Q33532788 | ||
| Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines | Q33611069 | ||
| Identification of small molecules enhancing autophagic function from drug network analysis | Q33712703 | ||
| Principal network analysis: identification of subnetworks representing major dynamics using gene expression data | Q33782519 | ||
| SAR monitoring of evolving compound data sets using activity landscapes | Q33820868 | ||
| Mapping of the benzodiazepine recognition site on GABA(A) receptors | Q33960772 | ||
| Discovery and preclinical validation of drug indications using compendia of public gene expression data | Q33995422 | ||
| Discovery of drug mode of action and drug repositioning from transcriptional responses | Q34093341 | ||
| A New Method for Computational Drug Repositioning Using Drug Pairwise Similarity | Q34246963 | ||
| Network context and selection in the evolution to enzyme specificity. | Q34296873 | ||
| Blocking oncogenic Ras signaling for cancer therapy | Q34311585 | ||
| Tackling antibiotic resistance | Q34390844 | ||
| Integrative genome-scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery | Q34627247 | ||
| New uses for old drugs | Q34661227 | ||
| Pathway-based drug repositioning using causal inference | Q35101594 | ||
| Exploiting drug-disease relationships for computational drug repositioning | Q35109885 | ||
| GASOLINE: a Greedy And Stochastic algorithm for optimal Local multiple alignment of Interaction NEtworks | Q35183918 | ||
| Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy | Q35882137 | ||
| Superessential reactions in metabolic networks | Q35935855 | ||
| Targeted cancer therapy | Q35953128 | ||
| Innovation: Rescuing drug discovery: in vivo systems pathology and systems pharmacology | Q36337927 | ||
| The proteomics big challenge for biomarkers and new drug-targets discovery | Q36432402 | ||
| Multi-target therapeutics: when the whole is greater than the sum of the parts | Q36697412 | ||
| A pathway-based view of human diseases and disease relationships | Q37073294 | ||
| Human metabolic network reconstruction and its impact on drug discovery and development | Q37158701 | ||
| Predicting metabolic biomarkers of human inborn errors of metabolism | Q37196179 | ||
| Prediction of drug-target interaction networks from the integration of chemical and genomic spaces. | Q37283297 | ||
| A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors | Q37395682 | ||
| A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. | Q37395737 | ||
| Unveiling the role of network and systems biology in drug discovery | Q37684484 | ||
| 'Pathway drug cocktail': targeting Ras signaling based on structural pathways | Q38129534 | ||
| Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery | Q41276143 | ||
| A Comparative Study of Metabolic Network Topology between a Pathogenic and a Non-Pathogenic Bacterium for Potential Drug Target Identification. | Q41858708 | ||
| Drug-target interaction prediction through domain-tuned network-based inference. | Q41888887 | ||
| Choke point analysis of metabolic pathways in E.histolytica: a computational approach for drug target identification | Q42918994 | ||
| Drug-target interaction prediction by learning from local information and neighbors | Q45371331 | ||
| A systems pharmacology analysis of major chemotherapy combination regimens used in gastric cancer treatment: predicting potential new protein targets and drugs | Q45749371 | ||
| Gaussian interaction profile kernels for predicting drug-target interaction. | Q45961548 | ||
| Estimating novel potential drug targets of Plasmodium falciparum by analysing the metabolic network of knock-out strains in silico | Q46551696 | ||
| Interaction of propofol and sevoflurane on loss of consciousness and movement to skin incision during general anesthesia | Q48694364 | ||
| SIGMA: a set-cover-based inexact graph matching algorithm. | Q51703663 | ||
| P921 | main subject | web application | Q189210 |
| P304 | page(s) | S4 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | BMC Systems Biology | Q4835949 |
| P1476 | title | DT-Web: a web-based application for drug-target interaction and drug combination prediction through domain-tuned network-based inference | |
| P478 | volume | 9 Suppl 3 |
| Q96126415 | A computational drug repositioning method applied to rare diseases: Adrenocortical carcinoma |
| Q45949988 | A novel computational method for inferring competing endogenous interactions. |
| Q36244997 | A review of connectivity map and computational approaches in pharmacogenomics. |
| Q28077880 | Biomolecular Network-Based Synergistic Drug Combination Discovery |
| Q92938986 | Drug databases and their contributions to drug repurposing |
| Q47323180 | Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery |
| Q64235548 | Network Pharmacology Analysis of in Gene-Phenotype |
| Q36247116 | Predicting drug-target interactions by dual-network integrated logistic matrix factorization |
| Q42529916 | Preface: BITS2014, the annual meeting of the Italian Society of Bioinformatics |
| Q58765551 | Probing the chemical-biological relationship space with the Drug Target Explorer |
| Q90715435 | QuartataWeb: integrated chemical-protein-pathway mapping for polypharmacology and chemogenomics |
| Q64992753 | Revealing Drug-Target Interactions with Computational Models and Algorithms. |
| Q58121969 | cuRnet: an R package for graph traversing on GPU |
Search more.